MD AG Joins Group Against Approval of Potent Narcotic

Dec 12, 2013 -- 9:51pm

A bipartisan group of attorneys including Maryland AG Doug Gansler is urging the FDA to reconsider a recent decision to approve a high-dose narcotic painkiller.  AG Doug Gansler says that the FDA went against the recommendation of its advisory panel in approving Zohydro ER in October.  The panel voted 11 to 2 against approval because the drug has a high potential for misuse and its lack of abuse-deterrent formulation.  Just before approving Zohydro ER, the FDA recommended reclassifying all hydrocodone products to Schedule II controlled substances because of their abuse potential.  In a letter to the FDA the Attorneys General said they don’t want to see another vicious cycle of overzealous pharmaceutical sales, doctors over-prescribing the drug and patients tampering with it – resulting in a nationwide prescription drug epidemic that claims thousands of lives.

Return to: WGMD Local News Blog

Michael Savage

9pm-12am


Coming Up
Coast to Coast AM, 12:00 a.m. - 5:00 a.m.